Simona Zarini
Concepts (359)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Resistance | 14 | 2026 | 1247 | 2.360 |
Why?
| | Lipid Metabolism | 3 | 2026 | 533 | 1.350 |
Why?
| | Muscle, Skeletal | 10 | 2026 | 1818 | 1.260 |
Why?
| | Eicosanoids | 8 | 2018 | 58 | 1.140 |
Why?
| | Leukotrienes | 10 | 2012 | 28 | 1.080 |
Why?
| | Weight Loss | 4 | 2026 | 858 | 0.980 |
Why?
| | Obesity | 13 | 2026 | 3131 | 0.950 |
Why?
| | Diabetes Mellitus, Type 2 | 8 | 2024 | 2623 | 0.850 |
Why?
| | Exercise | 5 | 2026 | 2213 | 0.800 |
Why?
| | Triglycerides | 4 | 2026 | 527 | 0.670 |
Why?
| | Adipose Tissue | 5 | 2026 | 642 | 0.640 |
Why?
| | 1-Acylglycerophosphocholine O-Acyltransferase | 3 | 2014 | 5 | 0.560 |
Why?
| | Mass Spectrometry | 5 | 2019 | 729 | 0.550 |
Why?
| | Neutrophils | 15 | 2017 | 1133 | 0.520 |
Why?
| | Arachidonic Acid | 6 | 2017 | 101 | 0.520 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 5 | 2019 | 175 | 0.510 |
Why?
| | Diglycerides | 3 | 2026 | 66 | 0.480 |
Why?
| | Ceramides | 4 | 2024 | 114 | 0.470 |
Why?
| | Arachidonate 5-Lipoxygenase | 9 | 2017 | 36 | 0.460 |
Why?
| | Sphingolipids | 3 | 2024 | 83 | 0.410 |
Why?
| | Myeloid Cells | 1 | 2014 | 149 | 0.380 |
Why?
| | Metabolomics | 1 | 2019 | 738 | 0.380 |
Why?
| | Cysteine | 5 | 2011 | 210 | 0.370 |
Why?
| | Dinoprostone | 6 | 2022 | 179 | 0.350 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2024 | 216 | 0.350 |
Why?
| | Leukotriene B4 | 9 | 2012 | 37 | 0.340 |
Why?
| | Insulin | 4 | 2025 | 2525 | 0.320 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2019 | 198 | 0.300 |
Why?
| | Peritonitis | 1 | 2009 | 82 | 0.280 |
Why?
| | Diabetic Retinopathy | 3 | 2019 | 211 | 0.260 |
Why?
| | Phospholipids | 5 | 2018 | 215 | 0.260 |
Why?
| | Retina | 5 | 2019 | 330 | 0.260 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 3 | 2006 | 38 | 0.260 |
Why?
| | Bone Marrow | 1 | 2009 | 310 | 0.260 |
Why?
| | Mitochondria, Muscle | 2 | 2026 | 125 | 0.260 |
Why?
| | Sarcolemma | 2 | 2024 | 33 | 0.250 |
Why?
| | Cell Communication | 1 | 2009 | 327 | 0.250 |
Why?
| | Lipids | 2 | 2024 | 714 | 0.240 |
Why?
| | Endoplasmic Reticulum | 2 | 2026 | 268 | 0.240 |
Why?
| | Physical Endurance | 2 | 2025 | 278 | 0.240 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2006 | 158 | 0.220 |
Why?
| | Macrophages | 5 | 2020 | 1532 | 0.220 |
Why?
| | Paracrine Communication | 1 | 2025 | 67 | 0.220 |
Why?
| | Calcimycin | 5 | 2014 | 36 | 0.210 |
Why?
| | Intra-Abdominal Fat | 2 | 2022 | 104 | 0.200 |
Why?
| | Phosphatidylcholines | 1 | 2024 | 131 | 0.200 |
Why?
| | Hyperinsulinism | 1 | 2024 | 115 | 0.190 |
Why?
| | Mitochondrial Diseases | 1 | 2023 | 94 | 0.190 |
Why?
| | Animals | 30 | 2024 | 38107 | 0.190 |
Why?
| | Arachidonic Acids | 1 | 2003 | 42 | 0.190 |
Why?
| | Resistance Training | 1 | 2025 | 186 | 0.180 |
Why?
| | Pancreas | 1 | 2025 | 343 | 0.180 |
Why?
| | Mice | 21 | 2024 | 18297 | 0.180 |
Why?
| | Leukotriene A4 | 7 | 2009 | 8 | 0.180 |
Why?
| | Humans | 39 | 2026 | 146342 | 0.180 |
Why?
| | Antioxidants | 2 | 2002 | 544 | 0.170 |
Why?
| | Stem Cells | 1 | 2025 | 613 | 0.160 |
Why?
| | Leukotriene Antagonists | 2 | 2019 | 24 | 0.160 |
Why?
| | Glutathione | 1 | 2002 | 369 | 0.160 |
Why?
| | Lipolysis | 1 | 2020 | 44 | 0.150 |
Why?
| | Diabetic Neuropathies | 1 | 2021 | 101 | 0.150 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 453 | 0.150 |
Why?
| | Acetates | 1 | 2019 | 78 | 0.140 |
Why?
| | Adult | 12 | 2026 | 41087 | 0.140 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1432 | 0.140 |
Why?
| | Myofibroblasts | 1 | 2020 | 149 | 0.140 |
Why?
| | Receptors, Leukotriene | 2 | 2011 | 13 | 0.140 |
Why?
| | Middle Aged | 10 | 2026 | 36619 | 0.140 |
Why?
| | Glucose Clamp Technique | 3 | 2024 | 199 | 0.130 |
Why?
| | Quinolines | 1 | 2019 | 191 | 0.130 |
Why?
| | Subcutaneous Fat | 3 | 2025 | 80 | 0.130 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5899 | 0.130 |
Why?
| | Liver | 1 | 2026 | 1864 | 0.130 |
Why?
| | Calcium Ionophores | 2 | 2014 | 3 | 0.130 |
Why?
| | Receptors, Prostaglandin E, EP2 Subtype | 1 | 2017 | 6 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 4 | 2024 | 576 | 0.130 |
Why?
| | Male | 15 | 2026 | 73396 | 0.120 |
Why?
| | Hydroxyeicosatetraenoic Acids | 3 | 2011 | 35 | 0.120 |
Why?
| | Cells, Cultured | 10 | 2025 | 4118 | 0.120 |
Why?
| | Endocannabinoids | 1 | 2017 | 55 | 0.120 |
Why?
| | Lysophospholipids | 2 | 2014 | 80 | 0.120 |
Why?
| | Phenotype | 1 | 2024 | 3206 | 0.110 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 371 | 0.110 |
Why?
| | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2014 | 4 | 0.110 |
Why?
| | Ependymoglial Cells | 1 | 2014 | 8 | 0.110 |
Why?
| | Female | 14 | 2026 | 79499 | 0.110 |
Why?
| | Intestinal Neoplasms | 1 | 2014 | 31 | 0.110 |
Why?
| | CD40 Antigens | 1 | 2014 | 69 | 0.100 |
Why?
| | Group IV Phospholipases A2 | 3 | 2014 | 46 | 0.100 |
Why?
| | Rats | 6 | 2024 | 5586 | 0.100 |
Why?
| | Bone Marrow Cells | 3 | 2017 | 328 | 0.100 |
Why?
| | Linoleoyl-CoA Desaturase | 1 | 2013 | 2 | 0.100 |
Why?
| | Inflammation | 6 | 2019 | 2919 | 0.100 |
Why?
| | Cell Membrane | 2 | 2007 | 701 | 0.100 |
Why?
| | Inflammation Mediators | 3 | 2009 | 508 | 0.100 |
Why?
| | Prostaglandins | 3 | 2011 | 94 | 0.100 |
Why?
| | Athletes | 3 | 2024 | 432 | 0.100 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2013 | 97 | 0.100 |
Why?
| | Cytosol | 2 | 2020 | 215 | 0.090 |
Why?
| | Chromatography, High Pressure Liquid | 5 | 2018 | 588 | 0.090 |
Why?
| | Models, Animal | 1 | 2014 | 387 | 0.090 |
Why?
| | Mice, Inbred C57BL | 9 | 2023 | 6034 | 0.090 |
Why?
| | Interleukin-13 | 2 | 2022 | 149 | 0.090 |
Why?
| | Retinal Degeneration | 1 | 2012 | 40 | 0.090 |
Why?
| | Culture Media, Conditioned | 2 | 2022 | 112 | 0.090 |
Why?
| | Safflower Oil | 1 | 2012 | 4 | 0.090 |
Why?
| | Mice, Transgenic | 4 | 2012 | 2134 | 0.090 |
Why?
| | Linoleic Acid | 1 | 2012 | 44 | 0.090 |
Why?
| | Glutathione Transferase | 3 | 2002 | 92 | 0.090 |
Why?
| | Retinal Neovascularization | 1 | 2011 | 29 | 0.090 |
Why?
| | Colitis | 1 | 2014 | 283 | 0.090 |
Why?
| | Cardiolipins | 1 | 2012 | 83 | 0.080 |
Why?
| | Intestines | 2 | 2014 | 351 | 0.080 |
Why?
| | Papilledema | 1 | 2011 | 44 | 0.080 |
Why?
| | Intestinal Mucosa | 2 | 2014 | 666 | 0.080 |
Why?
| | Glucose | 3 | 2025 | 1053 | 0.080 |
Why?
| | Phosphatidylglycerols | 1 | 2011 | 21 | 0.080 |
Why?
| | Leukocytes | 1 | 2012 | 301 | 0.080 |
Why?
| | Retinal Diseases | 1 | 2011 | 102 | 0.080 |
Why?
| | Phospholipases A2, Cytosolic | 1 | 2010 | 4 | 0.080 |
Why?
| | Mycoplasma pneumoniae | 1 | 2011 | 54 | 0.080 |
Why?
| | Lipoxygenase | 2 | 2017 | 15 | 0.080 |
Why?
| | Leukotriene C4 | 3 | 2012 | 6 | 0.080 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2011 | 56 | 0.080 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2010 | 82 | 0.080 |
Why?
| | Bone Marrow Transplantation | 2 | 2009 | 301 | 0.080 |
Why?
| | Pulmonary Surfactants | 1 | 2011 | 105 | 0.080 |
Why?
| | Ionophores | 3 | 2006 | 24 | 0.080 |
Why?
| | Thimerosal | 2 | 2008 | 6 | 0.080 |
Why?
| | Neuroglia | 2 | 2009 | 177 | 0.080 |
Why?
| | Zebrafish | 1 | 2014 | 536 | 0.080 |
Why?
| | Shock, Hemorrhagic | 1 | 2012 | 195 | 0.080 |
Why?
| | Oxidation-Reduction | 2 | 2024 | 1075 | 0.070 |
Why?
| | Retinal Vessels | 3 | 2019 | 79 | 0.070 |
Why?
| | Chemotaxis, Leukocyte | 3 | 2004 | 115 | 0.070 |
Why?
| | Zymosan | 1 | 2009 | 39 | 0.070 |
Why?
| | Synovial Membrane | 1 | 2010 | 130 | 0.070 |
Why?
| | Heart Failure | 2 | 2013 | 2329 | 0.070 |
Why?
| | Arthritis, Experimental | 1 | 2010 | 142 | 0.070 |
Why?
| | Enzymes | 1 | 2009 | 60 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2022 | 1224 | 0.070 |
Why?
| | Calcium | 2 | 2006 | 1181 | 0.070 |
Why?
| | Acute Lung Injury | 1 | 2012 | 312 | 0.070 |
Why?
| | Mice, Knockout | 6 | 2014 | 3125 | 0.070 |
Why?
| | Endothelial Cells | 1 | 2014 | 876 | 0.070 |
Why?
| | Metabolic Networks and Pathways | 1 | 2009 | 175 | 0.070 |
Why?
| | Mitochondria | 2 | 2012 | 997 | 0.070 |
Why?
| | Lysophosphatidylcholines | 1 | 2007 | 23 | 0.070 |
Why?
| | Macrophages, Alveolar | 1 | 2011 | 377 | 0.060 |
Why?
| | Adenosine Triphosphatases | 1 | 2007 | 158 | 0.060 |
Why?
| | Blotting, Western | 4 | 2012 | 1177 | 0.060 |
Why?
| | Pyrazoles | 1 | 2010 | 517 | 0.060 |
Why?
| | Sulfonamides | 1 | 2010 | 594 | 0.060 |
Why?
| | Thromboxanes | 1 | 2005 | 14 | 0.060 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2005 | 9 | 0.060 |
Why?
| | Isoprostanes | 1 | 2005 | 15 | 0.060 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2006 | 124 | 0.060 |
Why?
| | Phospholipases A | 1 | 2006 | 97 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2867 | 0.060 |
Why?
| | Glycogen | 1 | 2025 | 55 | 0.060 |
Why?
| | Hyperglycemia | 1 | 2009 | 384 | 0.060 |
Why?
| | Capillary Permeability | 2 | 2019 | 133 | 0.060 |
Why?
| | GTPase-Activating Proteins | 1 | 2025 | 81 | 0.060 |
Why?
| | Fibroblasts | 1 | 2010 | 1034 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2013 | 4580 | 0.050 |
Why?
| | Enzyme Activation | 1 | 2006 | 759 | 0.050 |
Why?
| | SRS-A | 1 | 2004 | 17 | 0.050 |
Why?
| | Receptors, IgE | 1 | 2004 | 43 | 0.050 |
Why?
| | Protein C | 1 | 2004 | 54 | 0.050 |
Why?
| | Bacterial Proteins | 1 | 2011 | 980 | 0.050 |
Why?
| | Ubiquinone | 1 | 2023 | 36 | 0.050 |
Why?
| | Carnitine | 1 | 2024 | 91 | 0.050 |
Why?
| | Membrane Proteins | 3 | 2008 | 1130 | 0.050 |
Why?
| | Brain Edema | 1 | 2004 | 63 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2007 | 411 | 0.050 |
Why?
| | Bronchial Hyperreactivity | 1 | 2004 | 104 | 0.050 |
Why?
| | Electron Transport | 1 | 2023 | 110 | 0.050 |
Why?
| | Fatty Liver | 1 | 2026 | 252 | 0.050 |
Why?
| | Signal Transduction | 4 | 2025 | 5246 | 0.050 |
Why?
| | Rats, Inbred SHR | 2 | 2013 | 36 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2025 | 441 | 0.050 |
Why?
| | Subcellular Fractions | 1 | 2003 | 73 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Saccharomyces cerevisiae | 1 | 2007 | 584 | 0.050 |
Why?
| | Chromatography, Gel | 1 | 2003 | 131 | 0.050 |
Why?
| | Mice, Inbred ICR | 1 | 2003 | 103 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 22 | 0.050 |
Why?
| | Sodium | 1 | 2004 | 196 | 0.050 |
Why?
| | Mast Cells | 1 | 2004 | 150 | 0.050 |
Why?
| | Adjuvants, Immunologic | 1 | 2004 | 245 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 83 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 56 | 0.050 |
Why?
| | Encephalitis | 1 | 2004 | 143 | 0.040 |
Why?
| | Chlorobenzenes | 3 | 2012 | 18 | 0.040 |
Why?
| | Superoxides | 2 | 2019 | 198 | 0.040 |
Why?
| | Vasodilation | 1 | 2025 | 519 | 0.040 |
Why?
| | Lipoxygenase Inhibitors | 3 | 2012 | 34 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 2022 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2022 | 268 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2002 | 163 | 0.040 |
Why?
| | Acute Disease | 1 | 2024 | 1038 | 0.040 |
Why?
| | Prostaglandins E, Synthetic | 1 | 2000 | 2 | 0.040 |
Why?
| | Phosphorylation | 1 | 2025 | 1724 | 0.040 |
Why?
| | Molecular Structure | 1 | 2002 | 484 | 0.040 |
Why?
| | Allergens | 1 | 2004 | 390 | 0.040 |
Why?
| | Peroxidases | 1 | 2000 | 28 | 0.040 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 76 | 0.040 |
Why?
| | Bronchitis | 1 | 2000 | 28 | 0.040 |
Why?
| | Lung Diseases, Obstructive | 1 | 2000 | 43 | 0.040 |
Why?
| | Vitamin E | 1 | 2001 | 123 | 0.040 |
Why?
| | Organotin Compounds | 1 | 2000 | 4 | 0.040 |
Why?
| | Myocardium | 2 | 2013 | 948 | 0.040 |
Why?
| | Substrate Specificity | 3 | 2008 | 389 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2004 | 597 | 0.040 |
Why?
| | Serine | 1 | 2021 | 142 | 0.040 |
Why?
| | Muscle, Smooth | 1 | 2000 | 152 | 0.040 |
Why?
| | Food Handling | 1 | 1999 | 33 | 0.040 |
Why?
| | Electroretinography | 1 | 2019 | 51 | 0.040 |
Why?
| | Plant Oils | 1 | 1999 | 33 | 0.040 |
Why?
| | Cyclopropanes | 1 | 2019 | 83 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2599 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2025 | 852 | 0.030 |
Why?
| | Phenols | 1 | 1999 | 106 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 974 | 0.030 |
Why?
| | Time Factors | 2 | 2008 | 7109 | 0.030 |
Why?
| | Dietary Fats | 1 | 2020 | 307 | 0.030 |
Why?
| | Sulfides | 1 | 2019 | 92 | 0.030 |
Why?
| | Adipocytes | 1 | 2020 | 223 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2019 | 173 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2022 | 784 | 0.030 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2019 | 154 | 0.030 |
Why?
| | Neurons | 1 | 2007 | 1668 | 0.030 |
Why?
| | Gene Expression Profiling | 2 | 2019 | 1792 | 0.030 |
Why?
| | Endothelium, Vascular | 3 | 2011 | 952 | 0.030 |
Why?
| | RAW 264.7 Cells | 1 | 2018 | 51 | 0.030 |
Why?
| | Hypersensitivity | 1 | 2001 | 253 | 0.030 |
Why?
| | Indoles | 3 | 2012 | 511 | 0.030 |
Why?
| | Lung Diseases | 1 | 2004 | 787 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2020 | 584 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2000 | 960 | 0.030 |
Why?
| | Cyclic AMP | 1 | 2017 | 208 | 0.030 |
Why?
| | Glycerol | 1 | 2017 | 90 | 0.030 |
Why?
| | Immunoblotting | 1 | 2017 | 294 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2014 | 1298 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 441 | 0.030 |
Why?
| | Cytokines | 2 | 2014 | 2081 | 0.030 |
Why?
| | Cyclooxygenase 2 | 2 | 2011 | 166 | 0.030 |
Why?
| | Body Mass Index | 1 | 2024 | 2458 | 0.030 |
Why?
| | Skin | 1 | 2020 | 701 | 0.030 |
Why?
| | Prostaglandin-E Synthases | 1 | 2014 | 5 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2014 | 64 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2014 | 132 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2014 | 112 | 0.030 |
Why?
| | RNA, Messenger | 3 | 2009 | 2791 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2017 | 1031 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 861 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2011 | 1712 | 0.020 |
Why?
| | Caspases | 1 | 2013 | 233 | 0.020 |
Why?
| | Transplantation Chimera | 1 | 2012 | 57 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 545 | 0.020 |
Why?
| | Peroxidase | 1 | 2012 | 168 | 0.020 |
Why?
| | Capillaries | 1 | 2012 | 123 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2014 | 444 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 74 | 0.020 |
Why?
| | Pericytes | 1 | 2011 | 42 | 0.020 |
Why?
| | Albumins | 1 | 2011 | 120 | 0.020 |
Why?
| | Lipopeptides | 1 | 2011 | 17 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 126 | 0.020 |
Why?
| | Celecoxib | 1 | 2010 | 41 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 823 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 150 | 0.020 |
Why?
| | Receptors, Leukotriene B4 | 1 | 2009 | 7 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 345 | 0.020 |
Why?
| | Lipoproteins | 1 | 2011 | 165 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2011 | 193 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 642 | 0.020 |
Why?
| | Biological Transport | 2 | 2004 | 424 | 0.020 |
Why?
| | Asthma | 1 | 2001 | 1800 | 0.020 |
Why?
| | Acetyltransferases | 1 | 2008 | 27 | 0.020 |
Why?
| | Hemodynamics | 1 | 2013 | 1114 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 846 | 0.020 |
Why?
| | Acyltransferases | 1 | 2008 | 78 | 0.020 |
Why?
| | Heart | 1 | 2012 | 626 | 0.020 |
Why?
| | Cell Count | 2 | 2000 | 315 | 0.020 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 1 | 2007 | 7 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2007 | 69 | 0.020 |
Why?
| | Acylation | 1 | 2007 | 30 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 1999 | 1041 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2010 | 494 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2008 | 526 | 0.020 |
Why?
| | Rabbits | 2 | 1999 | 651 | 0.020 |
Why?
| | Phosphatidylethanolamines | 1 | 2007 | 78 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 14330 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2007 | 117 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2007 | 245 | 0.020 |
Why?
| | Gene Expression | 1 | 2011 | 1463 | 0.020 |
Why?
| | Membrane Transport Proteins | 1 | 2007 | 154 | 0.010 |
Why?
| | Oxygen | 1 | 2011 | 997 | 0.010 |
Why?
| | Gene Deletion | 1 | 2007 | 385 | 0.010 |
Why?
| | Blood Platelets | 2 | 2000 | 382 | 0.010 |
Why?
| | Lung | 2 | 2012 | 4122 | 0.010 |
Why?
| | Cell Line | 1 | 2011 | 2814 | 0.010 |
Why?
| | Blood Pressure | 1 | 2012 | 1765 | 0.010 |
Why?
| | Goblet Cells | 1 | 2004 | 22 | 0.010 |
Why?
| | Leukopenia | 1 | 2004 | 33 | 0.010 |
Why?
| | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2004 | 4 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 11821 | 0.010 |
Why?
| | Nebulizers and Vaporizers | 1 | 2004 | 63 | 0.010 |
Why?
| | Sodium-Hydrogen Exchangers | 1 | 2004 | 23 | 0.010 |
Why?
| | Benzopyrans | 1 | 2004 | 31 | 0.010 |
Why?
| | Ovalbumin | 1 | 2004 | 187 | 0.010 |
Why?
| | Guinea Pigs | 1 | 2004 | 159 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 2004 | 290 | 0.010 |
Why?
| | Adoptive Transfer | 1 | 2004 | 197 | 0.010 |
Why?
| | Hyperplasia | 1 | 2004 | 164 | 0.010 |
Why?
| | Endotoxins | 1 | 2004 | 215 | 0.010 |
Why?
| | Aerosols | 1 | 2004 | 146 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 263 | 0.010 |
Why?
| | Microcirculation | 1 | 2004 | 142 | 0.010 |
Why?
| | Acetylcholine | 1 | 2004 | 209 | 0.010 |
Why?
| | Electric Stimulation | 1 | 2004 | 273 | 0.010 |
Why?
| | Biomarkers | 1 | 2014 | 4340 | 0.010 |
Why?
| | Organ Size | 1 | 2004 | 465 | 0.010 |
Why?
| | Immunoglobulin E | 1 | 2004 | 315 | 0.010 |
Why?
| | Blood-Brain Barrier | 1 | 2004 | 169 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2004 | 447 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2004 | 534 | 0.010 |
Why?
| | Trachea | 1 | 2004 | 253 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2537 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2004 | 1244 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2004 | 1361 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1761 | 0.010 |
Why?
| | Apoptosis | 1 | 2009 | 2439 | 0.010 |
Why?
| | Enzyme Induction | 1 | 2000 | 87 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2000 | 197 | 0.010 |
Why?
| | Adenylyl Cyclases | 1 | 2000 | 60 | 0.010 |
Why?
| | Arachidonate 15-Lipoxygenase | 1 | 2000 | 20 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 317 | 0.010 |
Why?
| | Isoenzymes | 1 | 2000 | 294 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2004 | 901 | 0.010 |
Why?
| | Olive Oil | 1 | 1999 | 3 | 0.010 |
Why?
| | Waste Management | 1 | 1999 | 11 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2004 | 2070 | 0.010 |
Why?
| | Free Radical Scavengers | 1 | 1999 | 81 | 0.010 |
Why?
| | Bronchi | 1 | 2000 | 263 | 0.010 |
Why?
| | Lipoproteins, LDL | 1 | 1999 | 119 | 0.010 |
Why?
| | Sputum | 1 | 2000 | 302 | 0.010 |
Why?
| | Epoxide Hydrolases | 1 | 1997 | 13 | 0.010 |
Why?
| | Bronchoconstriction | 1 | 1998 | 29 | 0.010 |
Why?
| | Chemotaxis | 1 | 1998 | 121 | 0.010 |
Why?
| | Cell Survival | 1 | 2000 | 1105 | 0.010 |
Why?
| | Thiophenes | 1 | 1997 | 117 | 0.010 |
Why?
| | Perfusion | 1 | 1997 | 255 | 0.010 |
Why?
| | Binding Sites | 1 | 1997 | 1309 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1827 | 0.010 |
Why?
| | Erythrocytes | 1 | 1997 | 750 | 0.010 |
Why?
| | Brain | 1 | 2004 | 2991 | 0.010 |
Why?
| | Adolescent | 1 | 2004 | 22557 | 0.000 |
Why?
| | Aged | 1 | 2000 | 26432 | 0.000 |
Why?
|
|
Zarini's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|